0
Inquiry Basket

There is no product in the shopping cart, buy it!

Quantitative Human AQP2 (Glycosylated) Sandwich ELISA Kit (CAT#: GLJF-0525-HX405)

Datasheet
SizeQtyAdd To Basket
1×48 T
1×96 T

Product Description The quantitative human AQP2 (glycosylated) sandwich ELISA kit is designed to detect human aquaporin 2 (AQP2) levels. AQP2 is a water channel protein primarily found in the kidneys, which plays a critical role in regulating water reabsorption in the collecting ducts. The kit is suitable for various biological samples such as tissue homogenates, urine. Its sensitivity is 0.142 ng/mL, which can accurately detect low concentrations of AQP2 in the sample.
Target AQP2
N-Glycosylation Site 123
Sample Types Tissue homogenates, urine
Sample Volume 100 μL
Sensitivity 0.142 ng/mL
Detection Principle Quantitative sandwich ELISA
Detection Range 0.55 ng/mL-15 ng/mL
Detection Time 1 h-5 h
Detection Wavelength 450 nm
Storage Store at 2-8°C for long term storage.
Species Human
Full Name Aquaporin 2
Alternate Names AQP2; Aquaporin 2; AQP-CD; Aquaporin-CD; Collecting duct water channel protein
Uniprot No. P41181
Application The quantitative human AQP2 (glycosylated) sandwich ELISA kit is used to measure glycosylated AQP2 levels in samples. This measurement is valuable in research and clinical settings for understanding kidney functions and water balance disorders. The kit is applied in studies of conditions such as diabetes insipidus, syndrome of inappropriate antidiuretic hormone secretion (SIADH), and other renal diseases.
Kit Components Pre-coated ELISA plate; Lyophilized standard; Biotin-labeled antibody; HRP-avidin; Various diluents; Wash buffer; TMB chromogenic substrate; Stop solution
Precision Intra-Assay: n=20, CV <8%;
Inter-Assay: n=20, CV <10%;
Recovery Serum sample: n=5, 80-100%;
Plasma sample: n=4, 85-105%;
Standard Curve
The standard curve is for reference only, and a new standard curve should be generated for each set of samples tested.
For Research Use Only.
Online Inquiry
Creative Biolabs-Glycoprotein Follow us on